Yi Zhang
Corporate Officer/Principal bei The University of North Carolina at Charlotte
Aktive Positionen von Yi Zhang
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| The University of North Carolina at Charlotte | Corporate Officer/Principal | - | - |
Karriereverlauf von Yi Zhang
Ehemalige bekannte Positionen von Yi Zhang
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| EPIZYME, INC. | Gründer | 01.11.2007 | - |
Ausbildung von Yi Zhang
| China Agricultural University | Graduate Degree |
| Florida State University | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 4 |
| China | 2 |
Operativ
| Founder | 1 |
| Corporate Officer/Principal | 1 |
| Graduate Degree | 1 |
Sektoral
| Consumer Services | 4 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Epizyme, Inc.
 Epizyme, Inc. BiotechnologyHealth Technology Epizyme, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the discovery, development, and commercialization of novel epigenetic medicines for cancer and other diseases. Its product pipeline is lead by, tazemetostat which targets Non-Hodgkin Lymphoma, molecularly defined solid tumors, non-small-cell lung carcinoma, molecularly targeted tumors, and ovarian cancer. The firm also develops pinometostat for genetically defined acute leukemia, and EZM8266 for sickle cell disease. The company was founded by Robert Horvitz and Zhang Yi on November 1, 2007 and is headquartered in Cambridge, MA. | Health Technology |